Xenetic Biosciences, Inc. Warrants
XBIOW
XBIOW was delisted on the 16th of July, 2024.
1 hedge funds and large institutions have $2K invested in Xenetic Biosciences, Inc. Warrants in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
33% less capital invested
Capital invested by funds: $3K → $2K (-$1K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$21 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $2K | -$21 | -12 | -0.8% |
|
XBIOW Hedge Fund Activity: Q4 2021 in Review
1 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences, Inc. Warrants (XBIOW) for Q4 2021, worth a combined $2K — down 33% from $3K a quarter earlier.
Fund positioning in XBIOW was balanced in Q4 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $21.
- 1 institutional investor held Xenetic Biosciences, Inc. Warrants (XBIOW) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $2K of Xenetic Biosciences, Inc. Warrants stock for Q4 2021, down 33% quarter-over-quarter.
- 0 funds opened new Xenetic Biosciences, Inc. Warrants positions in Q4 2021 and 0 closed out.
- The largest Xenetic Biosciences, Inc. Warrants seller in Q4 2021 was UBS Group, an estimated $21 sold.
Based on aggregated 13F filings for Q4 2021.